SEC Form 3 · accession 0000899243-19-001048
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vatera Capital Management LLC
Director · 10% Owner
Period of report
Jan 2, 2019
Accepted (ET)
Jan 11, 2019 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 16,007,237 | I | Held by Vatera Healthcare Partners LLC | |
| Common StockF1 | holding | — | — | — | 600,722 | I | Held by VHPM Holdings LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 2, 2019 Vatera Capital Management LLC ("VCM") was appointed as the manager of Vatera Healthcare Partners LLC and VHPM Holdings LLC. Kevin Ferro serves as the Chief Executive Officer and Managing Member of VCM. Pursuant to Rule 13d-3 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"), VCM may be deemed to beneficially own the shares held directly by Vatera Healthcare Partners LLC and VHPM Holdings LLC. VCM disclaims beneficial ownership of any shares owned by Vatera Healthcare Partners LLC or VHPM Holdings LLC, except to the extent of its pecuniary interest therein. Mr. Ferro serves on the Board of Directors of the Issuer (the "Board"). Solely for the purposes of Section 16 of the Exchange Act, VCM may be deemed to be a director-by-deputization as a result of the service of Mr. Ferro on the Board.